Skip to main content
SpringerLink
Log in

Ribavirin and Inosiplex: A Review of their Present Status in Viral Diseases

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

A considerable amount of information has accumulated during the past 10 years in the search for antiviral agents. Ribavirin and inosiplex are 2 interesting developments to come out of this search.

Ribavirin, a synthetic nucleoside, has an unusually wide spectrum of antiviral activity, especially when tested in vitro. A large number of RNA and DNA viruses are sensitive, especially herpes viruses, poxvirus, influenza, parainfluenza, reovirus, togavirus, and RNA tumour viruses. The in vivo antiviral spectrum of activity is much narrower, with activity against herpes virus, influenza, parainfluenza, measles and adenoviruses. However, controlled clinical trials have not been uniformly successful in treating influenza, hepatitis, herpes simplex and herpes zoster.

Inosiplex has been shown to have antiviral activity in vivo against influenza, herpes simplex, rhinovirus and vaccinia virus infections. However, antiviral activity has not been consistently demonstrated, and this observation led to further studies which revealed its immunomodulating effects. The accumulated evidence has indicated that inosiplex is more a prohost agent rather than an antiviral drug. Immune functions which are depressed during viral infection can be restored to normal by inosiplex therapy.

At present, neither ribavirin nor inosiplex alone has been shown to be uniformly successful in the treatment of human viral diseases. Nevertheless, their potential place in chemotherapy should not be neglected, although further data are needed to determine what this place will be. Whether combining them with other antiviral agents such as Interferon, acyclovir, Ara-A, and so on, would produce a potentiation of action and improved antiviral chemotherapy, will be an interesting area for further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allen, C.M. and Fingal, C.M.: Failure of type 1 herpes virus to develop resistance to ribavirin. Antimicrobial Agents and Chemotherapy 12: 120 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Allen, L.B.; Wolf, S.M.; Hintz, C.J.; Huffman, J.H. and Sidwell, R.W.: Effect of ribavirin on type 2 herpes virus hominis (HVH/2) in vitro and in vivo. Annals of the New York Academy of Sciences 284: 247 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Allen, L.F.; Huffman, J.H. and Sidwell, R.W.: Failure of 1-B-D-ribofuranosyl-l,2,4-triazole-2-carboxamide (virazole, ICN-1229) to stimulate interferon. Antimicrobial Agents and Chemotherapy 3: 534 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Allen, L.B.; Boswell, K.H.; Khwaja, T.A.; Myer, R.B. Jr.; Sidwell, R.W.; Witkowski, J.T.; Christenson, L.F. and Robins, R.K.: Synthesis and antiviral activity of some phosphates of the broadspectrum antiviral nucleotides, 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Ribavirin). Journal of Medicinal Chemistry 21: 743 (1978).

    Google Scholar 

  • Appleyard, G. and Maber, H.B.: A plaque assay for the study of influenza virus inhibitors; in Oxford and Williams (Eds) Chemotherapy and Control of Influenza, pp.49–53 (Academic Press, London 1976).

    Google Scholar 

  • Arensman, J.B.; Dominik, J.W. and Hilmas, D.E.: Effects of small-particle aerosols of ramantadine and ribavirin on arterial blood pH and gas tensions and lung water content of A2 influenza-infected mice. Antimicrobial Agents and Chemotherapy 12: 40 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Barnett, J.W.; Shepman, C., Jr. and Drach, J.C.: Effect of ribavirin on KB cell DNA synthesis; in Nelson and Grassi (Eds) Current Chemotherapy and Infectious Diseases. Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, Mass., 1–5 Oct. 1979, p.559 (American Society for Microbiology, Washington 1980).

    Google Scholar 

  • Berendt, R.F.; Walker, J.A.; Dominik, J.W. and Stephen, E.L.: Response of influenza virus infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol. Antimicrobial Agents and Chemotherapy 11: 1069 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Betts, R.F.; Douglas, R.G. Jr.; George, S.D. and Rinchart, C.J.: Isoprinosine in experimental influenza A infection in volunteers. 78th Annual Meeting of the American Society for Microbiology, Las Vega, Nevada, 14–19 May (1978).

  • Boyd, M.R.; Beeson, M.F.: Quoted by Allen, L.B.: Review of in vivo efficacy of ribavirin; in Smith and Kirkpatrick (Eds) Ribavirin: A Broadspectrum Antiviral Agent, p.43 (Academic Press, London 1980).

    Google Scholar 

  • Bradshaw, L.J. and Sumner, H.L.: In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection. Third Conference on Antiviral Substances, 2–5 Feb., 1976. Annals of the New York Academy of Sciences 284: 190 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Catlin, D.H.; Smith, R.A. and Samuels, A.I.: 14C-ribavirin: Distribution and pharmacokinetic studies in rats, baboons and man; in Smith and Kirkpatrick (Eds) Ribavirin: A Broad Spectrum Antiviral Agent, pp.88–98 (Academic Press, London 1980).

    Google Scholar 

  • Chang, T.W.: Prophylactic effect of isoprinosine in upper respiratory viral illness. The Philippine Journal of Microbiology and Infectious Diseases 4: 38 (1975).

    Google Scholar 

  • Chang, T.W. and Weinstein, L.: Antiviral activity of isoprinosine in vitro and in vivo. The American Journal of the Medical Sciences 265: 143 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Chany, C. and Cerrutti, I.: Enhancement of antiviral protection against encephalomycarditis virus by a combination of isoprinosine and interferon. Archives of Virology 55: 225 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Corey, L.; Chiang, W.T.; Reeves, W.E.; Stramm, W.E.; Brewer, L. and Holmes, K.K.: Effect of isoprinosine on the cellular immune response in initial genital herpes virus infection. Clinical Research 27: 41A (1979).

    Google Scholar 

  • Cohen, A.A.; Togo, Y.; Khakoo, R.; Waldman, R. and Sigel, M.: Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A. Journal of Infectious Diseases 133(Suppl): 114A (1976).

    Article  Google Scholar 

  • De Clercq, E.; Luczak, M.; Shugar, D.; Torrence, P.F.; Waters, J.A. and Witkop, B.: Effect of cytosine arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus. Proceedings of the Society for Experimental Biology and Medicine 151: 487 (1976).

    PubMed  Google Scholar 

  • Denes, A.E.; Ebert, J.W.; Berquist, K.R.; Murphy, B.L. and Maynard, J.E.: Antiviral effects of virazole in chronic hepatitis B surface antigen seropositive chimpanzees. Antimicrobial Agents and Chemotherapy 10: 571 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Descamps, J. and DeClercq, E.: Broad-spectrum antiviral activity of pyrazofurin (pyrazomycin); in Siegenthaler and Luthy (Eds) Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, Zurich, 18–23 Sept. 1977, Vol. I, p.354 (American Society for Microbiology, Washington 1978).

    Google Scholar 

  • Dowling, J.N.; Pastic, B. and Guevarra, L.O.: Effect of ribavirin on murine cytomegalovirus infection. Antimicrobial Agents and Chemotherapy 10: 809 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Drabikowska, A.K.; Dudyez, L. and Shugar, D.: Studies on the mechanism of antiviral action of 1-(B-D-RibofuranosyD-1,2,4-triazole-3-carboxamide (ribaviron). Journal of Chemistry 22: 653 (1979).

    CAS  Google Scholar 

  • Durr, F.W.; Lindh, H.F. and Forbes, M.: Efficacy of 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice. Antimicrobial Agents and Chemotherapy 7: 582 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Eriksson, B.; Helgstrand, E.; Johannson, N.G.; Larsson, A.; Misiorny, A.; Noren, J.O.; Philipson, L; Stenberg, K.; Stening, G.; Stridh, S. and Oberg, B.: Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrobial Agents and Chemotherapy 11: 946 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Feldman, S.; Hayes, F.A.; Chaudhary, S. and Ossi, M.: Inosiplex for localized herpes zoster in childhood cancer patients: A preliminary controlled study. Antimicrobial Agents and Chemotherapy 14: 495 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Fernandez, H.; Ribavirin: A summary of clinical trials — herpes genitalis and measles; in Smith and Kirkpatrick (Eds) Ribavirin: A Broad Spectrum Antiviral Agent, pp.215–230 (Academic Press, London 1980).

    Google Scholar 

  • Ginsberg, T.: Urinary excretion of purine metabolites in macaca mulatta following administration of inosine and 1 -(dimethyl-amino)-2-propanol, p-acetamidobenzoate. 5th International Congress of Pharmacology, San Francisco, 23–28 July [Abstr.] (1972).

  • Ginsberg, T. and Glasky, A.J.: Inosiplex: An immunomodulation model for the treatment of viral disease. 3rd Conference on Antiviral Substances, 2–5 Feb., 1976. Annals of the New York Academy of Sciences 284: 128(1977).

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg, T.; Simon, L.N. and Glasky, A.J.: Isoprinosine: Pharmacological and toxicological properties in animals; in Boissier, Lechat and Fichelle (Eds) 7th International Congress of Pharmacology, Paris, 16–21 July [Abstr.] (1978).

  • Glasgow, L.A. and Galasso, G.J.: Isoprinosine: Lack of antiviral activity in experimental model infections. Journal of Infectious Diseases 126: 162 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Glasky, A.J.; Settineri, R. and Lynes, T.E.: Isoprinosine: Therapeutic antiviral action against influenza A2 in the mouse. Advances in Antimicrobial and Antineoplastic Chemotherapy. Proceedings of the 8th International Congress of Chemotherapy, Prague, 1971 — 1/1: 319 (1972).

    Google Scholar 

  • Glasky, A.J.; Settineri, R. and Lynes, T.E.: Isoprinosine, a purine derivative; metabolic immunological and antiviral effects; in Meuwissen (Ed) Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency, a Molecular Defect, pp.156–172 (Academic Press, London 1975).

    Google Scholar 

  • Glasky, A.J.; Friebertshauser, G.E.; Halker, J.W.; Settineri, R.A. and Ginsberg, T.: The role of cell-mediated immunity in therapeutic action of isoprinosine on viral processes. Chemotherapy 6: 235 (1977).

    Google Scholar 

  • Gordon, P. and Brown, E.R.: The antiviral activity of isoprinosine. Canadian Journal of Microbiology 18: 1463 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Gordon, P.; Ronsen, B. and Brown, E.R.: Anti-herpes virus action of isoprinosine. Antimicrobial Agents and Chemotherapy 5: 153 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Goswami, B.B.; Borek, E. and Sharma, O.K.: The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochemical Biophysical Research Communication 89: 830 (1979).

    Article  CAS  Google Scholar 

  • Gutowski, G.E.; Sweeny, M.J.; DeLong, D.C.; Hamill, R.L. and Gerzon, K.: Biochemistry and biological effects of the pyrazofurins (pyrazomycins): Initial clinical trial. Annals of the New York Academy of Sciences 255: 544 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Haddad, F.S. and Risk, W.S.: Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study. Annals of Neurology 7: 188 (1980).

    Article  Google Scholar 

  • Hadden, J.W.; Hadden, E.M. and Doffey, R.G.: Isoprinosine augmentation of phytohemagglutinin-induced lympocyte proliferation. Infection and Immunity 13: 382 (1976).

    PubMed  CAS  Google Scholar 

  • Huffman, J.H.; Anderson, M.A.; Allen, L.B. and Sidwell, R.W.: Lack of suppression of resistance factors to infuenza infections in mice pretreated with virazole. Journal of Antimicrobial Agents and Chemotherapy 3: 79 (1977).

    Article  CAS  Google Scholar 

  • Huffman, J.H.; Sidwell, R.W.; Khare, G.P.; Witkowski, J.T.; Allen, L.B. and Robins, R.K.: In vitro effect of 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrobial Agents and Chemotherapy 3: 235 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Jahrling, P.B.; Hesse, R.A.; Eddy, G.A.; Johnson, K.M.; Callis, R.T. and Stephen, E.L.: Lassa virus infection of rhesus monkey: Pathogenesis and treatment with ribavirin. Journal of Infectious Diseases 141: 580 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Katz, E.; Margalith, E. and Winer, B.: Inhibition of vaccinia virus growth by the nucleoside analogue 1-B-D-ribofurano-syl-1,2,4-triazole-3-carboxamide (virazole, ribavirin). Journal of General Virology 32: 327 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Khare, G.P.; Sidwell, R.W.; Witkowski, J.T.; Simon, L.N. and Robins, R.K.: Suppression by 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN-1229) of influenza virus-induced infections in mice. Antimicrobial Agents and Chemotherapy 3: 517 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Larson, E.W.; Stephen, E.L. and Walker, J.S.: Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (Sendai) virus infections in mice. Antimicrobial Agents and Chemotherapy 10: 770 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Longley, S.; Dunning, R.L. and Waldman, R.H.: Effect of isoprinosine against challenge with A(H3N2)/Hong Kong influenza virus in volunteers. Antimicrobial Agents and Chemotherapy 3: 506 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Magnussen, C.R.; Douglas, R.G. Jr.; Betts, R.F.; Roth, F.K. and Meagher, M.P.: Double-blind evaluation of oral ribavirin (virazole) in experimental influenza A virus infection in volunteers. Antimicrobial Agents and Chemotherapy 12: 498 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Miller, J.P.; Streeter, D.G.,; Robins, R.K. and Simon, L.N.: The relationship between the metabolism of ribavirin and its proposed mechanism of action. Annals of New York Academy of Sciences 284: 211 (1977).

    Article  CAS  Google Scholar 

  • Minkoff, D.I. and Connor, J.D.: Clinical use of ribavirin and the treatment of herpes zoster in otherwise normal adults; in Smith and Kirkpatrick (Eds) Ribavirin: A Broad Spectrum Antiviral Agent, p.185 (Academic Press, London 1980).

    Google Scholar 

  • Morin, A.; Touraine, J.L.; Renoix, G. and Hadden, J.W.: Effects de l’ isoprinosine sur l’activation di lymphocytes humanis in vitro. 7th International Congress of Pharmacology, Paris, July 16–21, 1978. Symposium on new trends in human immunology and cancer immunotherapy. Montpellier. In press (1981).

    Google Scholar 

  • Moulias, R.; Proust, J. and Marescat, M.R.: Action of isoprinosine (inosiplex) in immunological parameters of aged people. International Congress of Pharmacology, Paris [Abstr.] (1978).

  • Muldoon, R.L.; Menzy, L. and Jackson, G.G.: Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrobial Agents and Chemotherapy 2: 224 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Muller, M.E.G.; Maidhof, A.; Taschner, H. and Zahn, R.K.: Virazole (1 -B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), a cytostatic agent. Biochemical Pharmacology 26: 1071 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Odelola, H.A.: Antiviral activity of virazole on replication of viruses isolated in Nigeria; in Siegenthaler and Luthy (Eds) Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, Zurich, 18–23 Sept. 1977. Vol. I, pp.334–335 (American Society for Microbiology, Washington 1978).

    Google Scholar 

  • Oxford, J.S.: Specific inhibitors of influenza virus replication as potential chemorophylactic agents. Antimicrobial Agents and Chemotherapy 1: 23 (1975).

    Google Scholar 

  • Pachuta, D.M.; Togo, Y.; Hornick, R.B.; Schwartz, A.R. and Tominaga, S.: Evaluation of isoprinosine in experimental human rhinovirus infection. Antimicrobial Agents and Chemotherapy 5: 403 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Peary, D.L.; Koff, W.C.; Hyman, D.S. and Knight, V.: Inhibition of lymphocyte proliferative responses by ribavirin. Infection and Immunity 29: 583 (1980).

    Google Scholar 

  • Potter, C.W.; Phair, J.P.; Vodinelich, L; Fenton, R. and Jennings, R.: Antiviral, immunosuppressive and antitumour effects of ribavirin. Nature 259: 496 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Povey, C: In vitro antiviral efficacy of ribavirin against feline calici virus, feline viral rhinotracheitis virus, and canine parainfluenza virus. American Journal of Veterinary Research 39: 175 (1978).

    PubMed  CAS  Google Scholar 

  • Prostic, B.; Dowling, J.N. and Guevarra, L.O.: Effect of ribavirin on marine cytomegalovirus infection. Antimicrobial Agents and Chemotherapy 10: 809 (1976).

    Article  Google Scholar 

  • Prusiner, P. and Sundaralingam, M.: A new class of synthetic nucleoside analogues with broad-spectrum antiviral properties. Nature New Biology 244: 116 (1973).

    PubMed  CAS  Google Scholar 

  • Renoux, G.; Renoux, M.; Guillaumin, J.M. and Gonzien, C.: In vivo and in vitro immunostimulant activities of isoprinosine. Immunopharmacology 1: 415 (1979).

    Article  CAS  Google Scholar 

  • Salido-Rengell, F.; Nasser-Quinones, H. and Briseno-Garcia, B.: Clinical evaluation of 1-B-D-ribofuranoxyl-1,2,4-triazole-3 carboxamide (ribavirin) in a double-blind study during an outbreak of influenza. 3rd Conference on Antiviral Substances, 2–5 Feb. 1976. Annals of the New York Academy of Sciences 284: 272(1977).

    Article  PubMed  CAS  Google Scholar 

  • Sarver, N. and Stroller, V.: Virazole prevents production of sindbis virus and virus-induced cytophthic effect in aedes alopictus cells. Virology 91: 267 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Sato, A.J.; Hall, T.S. and Reed, S.E.: Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers. Antimicrobial Agents and Chemotherapy 3: 332 (1973).

    Article  Google Scholar 

  • Schoub, B.D. and Prozesky, O.W.: Antiviral activity of ribavirin in rotavirus gastroenteritis of mice. Antimicrobial Agents and Chemotherapy 12: 543 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Shannon, W.M.: Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo. Annals of the NY Academy of Sciences 284: 472 (1977).

    Article  CAS  Google Scholar 

  • Sidwell, R.W. and Witkowski, J.T.: Part II; in Wolff (Ed) Burger’s Medicinal Chemistry, 4th Ed., p.458 (Wiley, New York 1979).

    Google Scholar 

  • Sidwell, R.W.; Huffman, J.H.; Khare, G.P.; Allen, L.B.; Witowski, J.T. and Robins, R.K.: Broad spectrum antiviral activity of virazole: 1-B-D-ribofuranoxyl-1,2,4-triazole-3-carboxamide. Science 1977: 705 (1972).

    Article  Google Scholar 

  • Sidwell, R.W.; Simon, L.N.; Witkowski, J.T. et al.: Antiviral activity of virazole: Review and structure-activity relationships. Proceedings of the 8th International Congress of Chemotherapy, Athens, Greece. Progress in Chemotherapy 2: 903 (1974).

    Google Scholar 

  • Sidwell, R.W.; Khare, G.P.; Allen, L.B.; Huffman, J.H.; Witkowski, J.T.; Simon, L.N. and Robins, R.K.: In vitro and in vivo effect of 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfluenza virus infections. Chemotherapy 6: 279 (1975).

    Google Scholar 

  • Sidwell, R.W.: Ribavirin: A broad spectrum antiviral having clinical usefulness; in Liker (Ed) New Trends in Microbiology. Proceedings of the 1976 Congress of Yugoslav Microbiologists, Bled, Yugoslavia, p.367 (1977).

    Google Scholar 

  • Simon, L.N.; Settineri, R.; Coats, H. and Glasky, A.J.: Isoprinosine: Integration of the antiviral and immunoproliferative effects; in Siegenthaler and Luthy (Eds) Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, Zurich, 18–23 Sept. 1977, Vol. I, pp.366–368 (American Society for Microbiologists, Washington 1978).

    Google Scholar 

  • Simon, L.N. and Glasky, A.J.: Isoprinosine: An overview. Proceedings of the 4th Conference on Immune Modulation and Control of Neoplasia by Adjuvant Therapy, Bethesda, Maryland, 29–31 March. Cancer Treatment Report 62: 1963 (1978).

    CAS  Google Scholar 

  • Smee, D.F.; Spendlove R.S.; Barnett, B.B.; and Sidwell, R.W.: Quoted by Sidwell, R.W.: Ribavirin: In vitro antiviral activity; in Smith and Kirkpatrick (Eds) Ribavirin: A Broad Spectrum Antiviral Agent, p.35 (Academic Press, London 1980).

    Google Scholar 

  • Smith, R.A.: Mechanisms of action of ribavirin; in Smith and Kirkpatrick (Eds) Ribavirin: A Broad Spectrum Antiviral Agent, p.99 (Academic Press, London 1980).

    Google Scholar 

  • Smith, C.B.; Charette, R.P.; Fox, J.P.; Cooney, M.K. and Hall, C.E.: Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. Journal of Infectious Diseases 141: 548 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Smith, R.A.; Sidwell, R.W. and Robins, R.K.: Antiviral mechanisms of action. Annual Review of Pharmacology and Toxicology 20: 259 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Stephen, E.L.; Jones, D.E.; Peters, C.J.; Eddy, G.A.; Loizeaux, P.S.; and Jahrling, P.B.: Ribavirin treatment of Togo-, Arena- and Bunyavirus infections in subhuman primates and other laboratory animal species; in Smith and Kirkpatrick (Eds) Ribavirin: A Broadspectrum Antiviral Agent, p.169 (Academic Press, London 1980).

    Google Scholar 

  • Streeter, D.G.; Simon, L.N.; Khare, G.P., and Robins, R.K.: Biochemical studies on the mechanism of antiviral action of virazole. Federation Proceedings 32: 703 (1973).

    Google Scholar 

  • Streeter, D.G.; Miller, J.P.; Robins, R.K.; Sidwell, R.W.; Bauer, B.J.; Robins, R.K. and Simons, L.N.: The enzymic conversion of 1,2,4-triazole-3-carboxamide to ribavirin-5’-phosphate and its relationship to the proposed mechanism of action. Third Conference on Antiviral Substances, 2–5 Feb. 1976. Annals of the New York Academy of Sciences 284: 201 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Streeter, D.G.; Witkowski, J.T.; Khare, G.P.; and Simon, L.W.: Mechanism of action of 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad spectrum antiviral agent. Proceedings of the National Academy of Sciences 70: 1174 (1973).

    Article  CAS  Google Scholar 

  • Tisdale, M. and Bauer, D.J.: The relative potencies of anti-influenza compounds. 3rd Conference on Antiviral Substances, 2–5 Feb. 1976. Annals of the New York Academy of Sciences 284: 254 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Togo, Y.: In vitro effect of virazole against influenza viruses. Antimicrobial Agents and Chemotherapy 4: 641 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Togo, Y. and McCracken, E.A.: Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus. Journal of Infectious Diseases 133(Suppl): 109A (1976).

    Article  Google Scholar 

  • Waldman, R.H. and Ganguly, R.: Therapeutic efficacy of inosiplex (isoprinosine) in rhinovirus infection. 3rd Conference on Antiviral Substances, 2–5 Feb. 1976. Annals of the New York Academy of Sciences 284: 153 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Wickett, W.H. Jr.; Bradshaw, J. and Glasky, A.J.: Clinical effectivess of the immunopotentiating agent, inosiplex in herpes virus infections. American Society of Microbiology, Abstr. (1976).

    Google Scholar 

  • Willis, R.C.; Carson, D.A. and Seegmiller, J.E.: Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proceedings of the National Academy of Sciences 75: 3042 (1978).

    Article  CAS  Google Scholar 

  • Witkowski, J.T.; Fuertes, M.; Cook, P.D. and Robins, R.K.: Nucleosides of 1,2,4-triazole-3-carboxamide: Synthesis of certain pentofuranosyl, deoxypentofuranosyl and pentopyranosyl 1,2,4-triazoles. Journal of Carbohydrates, Nucleosides, Nucleotides 2: 1 (1975).

    CAS  Google Scholar 

  • Witkowski, J.T.; Robins, R.K.; Sidwell, R.W. and Simon, L.N.: Design, synthesis and broad spectrum antiviral activity of 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. Journal of Medicinal Chemistry 15: 1150 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Wybran, J. et al.: Inosiplex, a stimulating agent for normal human T cells and human leukocytes. Journal of Immunology 121: 1184 (1978).

    CAS  Google Scholar 

  • Zimmerman, T.P. and Deeprose, R.D.: Metabolism of 5-amino-1-B-D-ribofuran sylimidazole-4-carboxamide and related five-membered heterocycles to 5’-triphosphates in human blood and L5178Y cells. Biochemical Pharmacology 7: 709 (1978).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Service, New England Medical Center Hospital and Department of Medicine, Tufts University School of Medicine, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA

    Te-Wen Chang & R. C. Heel

  2. Australasian Drug Information Services, Auckland, New Zealand

    Te-Wen Chang & R. C. Heel

Authors
  1. Te-Wen Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. C. Heel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, TW., Heel, R.C. Ribavirin and Inosiplex: A Review of their Present Status in Viral Diseases. Drugs 22, 111–128 (1981). https://doi.org/10.2165/00003495-198122020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198122020-00002

Keywords

Search

Navigation